Karyopharm Therapeutics, Inc. (KPTI)
8.06
+0.08
(+1.00%)
USD |
NASDAQ |
May 21, 16:00
8.06
0.00 (0.00%)
After-Hours: 19:59
Karyopharm Therapeutics EPS Diluted (Quarterly) : -1.236 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.612 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Altimmune, Inc. | -0.1813 |
| Cellectar Biosciences, Inc. | -1.333 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.39M |
| Revenue (Quarterly) | 35.07M |
| Total Expenses (Quarterly) | 57.46M |
| Enterprise Value | 320.87M |
| Gross Profit Margin (Quarterly) | 96.13% |
| Profit Margin (Quarterly) | -63.86% |
| Earnings Yield | -187.2% |
| Normalized Earnings Yield | -156.93 |